Search

Your search keyword '"Espinosa Pereiro, Juan"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Espinosa Pereiro, Juan" Remove constraint Author: "Espinosa Pereiro, Juan"
143 results on '"Espinosa Pereiro, Juan"'

Search Results

1. Tuberculosis contact tracing, Angola/Suivi des contacts pour la tuberculose en Angola/Rastreo de contactos de tuberculosis en Angola

3. A longitudinal prospective study of active tuberculosis in a Western Europe setting: insights and findings

6. A non-randomized pragmatic historically controlled trial evaluating the effectiveness and safety of a bedaquiline or a linezolid-based short regimen for rifampicin-resistant tuberculosis

7. Imported schistosomiasis in travelers: Experience from a referral tropical medicine unit in Barcelona, Spain

8. Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

9. Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial

12. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

13. Endomyocardial involvement in asymptomatic Latin American migrants with eosinophilia related to helminth infection: A pilot study.

14. Usefulness of Xpert MTB/RIF and Xpert Ultra to Categorize Risk of Tuberculosis Transmission to Household Contacts.

15. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

17. A Systematic Review of Potential Biomarkers for Bacterial Burden and Treatment Efficacy Assessment in Tuberculosis Platform-Based Clinical Trials.

20. Adherence and Toxicity during the Treatment of Latent Tuberculous Infection in a Referral Center in Spain

21. Corrigendum to “Epidemiological and clinical profile of adult patients with diarrhoea after international travel attended in an International Health referral center” [Trav Med Infect Dis 45 (2022) 102216]

22. Post-infectious irritable bowel syndrome following a diagnosis of traveller’s diarrhoea: a comprehensive characterization of clinical and laboratory parameters.

24. Imported Strongyloides stercoralis infection and diabetes mellitus and other metabolic diseases: Is there any association?

25. Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial

26. Case Report: Leishmaniasis in a 33-Year-Old Man with Multiple Sclerosis

27. Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab

28. MDR Tuberculosis Treatment

29. Association Between Trypanosoma cruzi DNA in Peripheral Blood and Chronic Chagasic Cardiomyopathy : A Systematic Review

32. MDR Tuberculosis Treatment

33. Epidemiological and clinical profile of adult patients with diarrhoea after international travel attended in an International Health referral center

34. Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial.

35. COVID-19 Clinical Profile in Latin American Migrants Living in Spain: Does the Geographical Origin Matter?

36. Risk of SARS-CoV-2 Infection in Previously Infected and Non-Infected Cohorts of Health Workers at High Risk of Exposure

37. Risk of Trypanosoma cruzi infection among travellers visiting friends and relatives to continental Latin America

38. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

39. Risk of Trypanosoma cruzi infection among travellers visiting friends and relatives to continental Latin America

40. Blastocystis sp. Carriage and Irritable Bowel Syndrome : Is the Association Already Established?

41. Exposing and Overcoming Limitations of Clinical Laboratory Tests in COVID-19 by Adding Immunological Parameters; A Retrospective Cohort Analysis and Pilot Study.

42. Blastocystis sp. Carriage and Irritable Bowel Syndrome: Is the Association Already Established?

43. Early outcomes of tocilizumab in adults hospitalized with severe COVID19. An initial report from the Vall dHebron COVID19 prospective cohort study

45. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

46. Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study

47. Usefulness of FDG PET/CT in the management of tuberculosis

50. Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab

Catalog

Books, media, physical & digital resources